Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.

Stem cell research - 1 Jan 2020

Chen Muwan, Maimaitili Muyesier, Buchholdt Susanne Hvolbøl, Jensen Uffe Birk, Febbraro Fabia, Denham Mark

Abstract excerpt

We generated eight induced pluripotent stem cell (iPSC) lines from Parkinson's disease (PD) patients with different familial mutations using non-integrating episomal plasmids. All iPSC lines have a normal karyotype, express pluripotent genes including POU5F1, NANOG, and show alkaline phosphatase activity, as well as the ability to differentiate into all three germ layers. These PD iPSC lines can be used for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line
Share to Induced Pluripotent Stem Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Parkinson Disease

Source

Identifiers

PMID: 31786474
DOI: 10.1016/j.scr.2019.101657

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations.PMID 31786474Read ↗

Using induced pluripotent stem cells for modeling Parkinson’s diseaseSemantic proximity Read ↗

Modeling Parkinson’s Disease Using Patient-specific Induced Pluripotent Stem CellsSemantic proximity Read ↗

Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation.Semantic proximity Read ↗

Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s DiseaseSemantic proximity Read ↗

Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.Semantic proximity Read ↗

Modeling Parkinson’s Disease Using Induced Pluripotent Stem CellsSemantic proximity Read ↗

Generation of an induced pluripotent stem cell line (DANi-011A) from a Parkinson's disease patient with a LRRK2 p.G2019S mutation.Semantic proximity Read ↗

Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discoverySemantic proximity Read ↗

Generation of an induced pluripotent stem cell line (GIBHi003-A) from a Parkinson's disease patient with mutant PINK1 (p. I368N).Semantic proximity Read ↗

Generation of two isogenic control iPSC lines (LCSBi001-A-2 and LCSBi001-A-3) from a Parkinson's disease patient line (LCSBi001-A) carrying the pathogenic VPS35 p.D620N mutation.Semantic proximity Read ↗

Generation and characterization of induced pluripotent stem cell (iPSC) lines of two asymptomatic individuals carrying a heterozygous exon 7 deletion in Parkin (PRKN) and two non-carriers from the same family.Semantic proximity Read ↗

Induced pluripotent stem cells and Parkinson's disease: modelling and treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.